Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor)
J A Neder, S Andreoni, C Peres, L E Nery, J A Neder, S Andreoni, C Peres, L E Nery
Abstract
Carbon monoxide diffusing capacity (DLCO) or transfer factor (TLCO) is a particularly useful test of the appropriateness of gas exchange across the lung alveolocapillary membrane. With the purpose of establishing predictive equations for DLCO using a non-smoking sample of the adult Brazilian population, we prospectively evaluated 100 subjects (50 males and 50 females aged 20 to 80 years), randomly selected from more than 8,000 individuals. Gender-specific linear prediction equations were developed by multiple regression analysis with single breath (SB) absolute and volume-corrected (VA) DLCO values as dependent variables. In the prediction equations, age (years) and height (cm) had opposite effects on DLCOSB (ml min-1 mmHg-1), independent of gender (-0.13 (age) + 0.32 (height) - 13.07 in males and -0.075 (age) + 0.18 (height) + 0.20 in females). On the other hand, height had a positive effect on DLCOSB but a negative one on DLCOSB/ VA (P < 0.01). We found that the predictive values from the most cited studies using predominantly Caucasian samples were significantly different from the actually measured values (P < 0.05). Furthermore, oxygen uptake at maximal exercise (VO2max) correlated highly to DLCOSB (R = 0.71, P < 0.001); this variable, however, did not maintain an independent role to explain the VO2max variability in the multiple regression analysis (P > 0.05). Our results therefore provide an original frame of reference for either DLCOSB or DLCOSB/VA in Brazilian males and females aged 20 to 80 years, obtained from the standardized single-breath technique.
Source: PubMed
Prochains essais cliniques
-
Riphah International UniversityRecrutement
-
Riphah International UniversityRecrutementFibrose kystique (FK)Pakistan
-
AbelZeta Inc.Pas encore de recrutementLupus érythémateux disséminé (LED) | Néphrite lupique (LN)
-
Jiangsu Aidea Pharmaceutical Group Co., Ltd.RecrutementParticipants adultes en bonne santéChine
-
Alterity TherapeuticsPas encore de recrutementAtrophie multisystématiséeFrance
-
Azienda Ospedaliero-Universitaria di ParmaRecrutementComplication postopératoire | Complications cardiaques | Complications respiratoiresItalie
-
Zhejiang UniversityPas encore de recrutementCholangiocarcinome | Carcinome des voies biliairesChine
-
Loughborough UniversityRecrutementQualité de vie | Douleur articulaire | Dormir | Cognition | Force musculaire | Modifications de la composition corporelle | Biomarqueurs du métabolisme osseux | Biomarqueurs de l'inflammation | Symptôme de fatigue | Symptômes de la ménopause | Blood Pressure and Augmentation Index | Gastrointestinal ComfortRoyaume-Uni
-
Applied Food Sciences Inc.The Center for Applied Health Sciences, LLCRecrutementHealthy Subjects With Low Energy LevelsÉtats-Unis
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Pas encore de recrutement
-
Biogipuzkoa Health Research InstituteBiobizkaia Health Research InstituteRecrutementCancer | Déficience cognitive | Changement cognitifEspagne
-
Ludwig-Maximilians - University of MunichRecrutementAtrophie optique, autosomique dominante | Mutation du gène OPA1Allemagne